ribavirin has been researched along with Liver Failure, Acute in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hassebroek, AM; Heffron, CL; Mahsoub, HM; Meng, XJ; Sooryanarain, H; Tian, D; Wang, B | 1 |
| Borena, W; Graziadei, I; Oberhuber, G; Wenter, C | 1 |
| Buzas, C; Ciobanu, L; Tantau, M | 1 |
| Fernández-Cuenca, F; López-Hernández, I; Paniagua-García, M; Ríos-Villegas, MJ | 1 |
| Bhasin, D; Pollinger, H; Rubin, RA; Shrestha, R; Stein, L; Tracy, B | 1 |
| Marks, K; Talal, AH; Wan, DW; Yantiss, RK | 1 |
| Roberts, EA; Yeung, LT | 1 |
| Fujiwara, K; Yasui, S; Yokosuka, O | 1 |
| Acharya, SK; Goyal, R; Kumar, A; Panda, SK; Paul, SB | 1 |
| Chang, WY; Chuang, WL; Dai, CY; Hou, NJ; Yu, ML | 1 |
| Adamson, G; Bell, D; Biessels, P; Brookes, S; Fung, L; Ghanekar, A; Gorczynski, R; He, W; Koscik, C; Levy, A; Levy, GA; Ma, MX; McGilvray, ID; Ng, NF; Phillips, MJ; Rowe, A; Scrocchi, LA; Woods, C | 1 |
| Fukushima, K; Inoue, J; Iwasaki, T; Kakazu, E; Kido, O; Kimura, O; Kogure, T; Matsuda, Y; Nagasaki, F; Nakagome, Y; Obara, N; Shimosegawa, T; Ueno, Y; Wakui, Y | 1 |
1 review(s) available for ribavirin and Liver Failure, Acute
| Article | Year |
|---|---|
Current issues in the management of paediatric viral hepatitis.
Topics: Adult; Antiviral Agents; Child; Child, Preschool; Female; Hepatitis A; Hepatitis A Vaccines; Hepatitis A Virus, Human; Hepatitis B; Hepatitis B Vaccines; Hepatitis E; Hepatitis E virus; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Liver Failure, Acute; Polyethylene Glycols; Pregnancy; Recombinant Proteins; Ribavirin; Vaccination; Viral Hepatitis Vaccines | 2010 |
11 other study(ies) available for ribavirin and Liver Failure, Acute
| Article | Year |
|---|---|
Two mutations in the ORF1 of genotype 1 hepatitis E virus enhance virus replication and may associate with fulminant hepatic failure.
Topics: Female; Genotype; Hepatitis E; Hepatitis E virus; Humans; Liver Failure, Acute; Mutation; Pregnancy; Ribavirin; Virus Replication | 2022 |
Acute liver failure in immunocompetent patients infected with hepatitis E.
Topics: Aged; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Liver Failure, Acute; Male; Ribavirin | 2019 |
Fatal acute liver failure during Ritonavir-boosted Paritaprevir, Ombitasvir and Dasabuvir plus Ribavirin therapy.
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Liver Failure, Acute; Ribavirin; Ritonavir | 2017 |
Acute fulminant hepatitis B during hepatitis C virus therapy with direct-acting antivirals in a patient co-infected with HIV.
Topics: Anti-HIV Agents; Antiviral Agents; Benzimidazoles; Coinfection; Drug Substitution; Fatal Outcome; Fluorenes; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Liver Failure, Acute; Male; Middle Aged; Oligopeptides; Ribavirin; Sofosbuvir; Virus Activation | 2017 |
Liver transplantation for fulminant genotype 2a/c hepatitis C virus marked by a rapid recurrence followed by cure.
Topics: Acute Disease; Administration, Oral; Antiviral Agents; Carbamates; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Imidazoles; Liver Failure, Acute; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Risk Factors; Sofosbuvir; Valine | 2017 |
Autoimmune hepatitis in the HIV-infected patient: a therapeutic dilemma.
Topics: Antiviral Agents; Female; Hepatitis C, Chronic; Hepatitis, Autoimmune; HIV Infections; Humans; Interferons; Liver Failure, Acute; Liver Function Tests; Male; Middle Aged; Ribavirin; Treatment Outcome | 2009 |
Autoimmune fulminant hepatic failure in chronic hepatitis C during Peg-interferon-alpha 2b plus ribavirin treatment showing histological heterogeneity.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Interferon alpha-2; Interferon-alpha; Liver Failure, Acute; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2011 |
Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report.
Topics: Adolescent; Antiviral Agents; End Stage Liver Disease; Female; Genotype; Hepatitis E; Hepatitis E virus; Humans; Liver Failure, Acute; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Treatment Outcome | 2012 |
Successful treatment of fulminant hepatitis C by therapy with alpha interferon and ribavirin.
Topics: Antiviral Agents; Female; Hepatitis C; Humans; Interferon Type I; Liver; Liver Failure, Acute; Middle Aged; Recombinant Proteins; Ribavirin | 2005 |
Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activity.
Topics: Animals; Antiviral Agents; Coronavirus Infections; Drug Delivery Systems; Female; Hepatitis, Viral, Animal; Hepatocytes; Liver Failure, Acute; Macrophages; Mice; Mice, Inbred BALB C; Murine hepatitis virus; Outcome Assessment, Health Care; Ribavirin; Virus Replication | 2006 |
Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment.
Topics: Adult; Antiviral Agents; Biopsy; Drug Therapy, Combination; Female; Hepatitis C; Hepatitis, Autoimmune; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Failure, Acute; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2007 |